Logo Image
News
All NewsAAP NewsPNP Corner
Media
Clinical Forum InsightsCure ConnectionsExpert InterviewsInsightsMedcastPeer ExchangePeers & PerspectivesPodcastsShortsSpecial ReportsSponsored VideosWebinars
Puzzler
Publications
Contemporary Pediatrics JournalSupplements And Featured Publications
More
CME/CE
Resources
HandoutsJob BoardProduct ProfileSponsored
Conferences
Conference CoverageConference Listing
Partnerships
Editorial
Editorial Advisory BoardWriter’s GuidelinesReference GuidelinesMeet the Editors

Subscribe

  • News
  • Media
  • Puzzler
  • Publications
  • CME/CE
  • Resources
  • Conferences
  • Partnerships
  • Subscribe
  • Editorial
  • Allergy, Immunology, and ENT
    • Food Allergies
    • Animal Allergies
  • Cardiology
    • Cardiovascular Diseases
  • Dermatology
    • Hidradenitis Suppurativa
    • Atopic Dermatitis
    • Acne
  • Emergency Medicine
  • Endocrinology
    • Type 1 Diabetes
    • Type 2 Diabetes
  • Gastroenterology
    • Formula
    • Obesity
  • Genetic Disorders
  • Genetic Testing
  • Infectious Diseases
    • COVID-19
    • RSV
    • Influenza
    • Antibiotic Resistance
    • Vaccination and Immunization
    • Bacterial Conjunctivitis
    • Pneumonia
    • Sexually Transmitted Diseases
  • Mental, Behavioral and Development Health
    • Anxiety
    • Autism
    • Developmental/Behavioral Disorders
    • Depression
    • Psychiatry
    • ADHD
    • Addiction
    • Antisocial Personality Disorder
  • Neurology
    • Concussion
    • Epilepsy
    • Headache
  • Nutrition
  • OB/GYN
    • Neonatal/Perinatology
  • Pain
  • Pharmacology
    • Drug Pipeline News
  • Practice Improvement
    • Telemedicine
  • Rare Disease
  • Respiratory
    • Asthma
    • Cystic Fibrosis
  • Rheumatology
Advertisement
|Articles|August 1, 2003

Study supports limiting off-label fluoroquinolone use

Advertisement
Advertisement
Infectious Diseases

Related Content

Advertisement
FDA expands TOFIDENCE (tocilizumab-bavi) indications to include CAR T-cell–induced CRS and pediatric COVID-19

FDA expands TOFIDENCE (tocilizumab-bavi) indications to include CAR T-cell–induced CRS and pediatric COVID-19

ByMorgan Ebert, Executive Editor
June 10th 2026
FDA accepts vedolizumab sBLA for pediatric ulcerative colitis and Crohn's disease

FDA accepts vedolizumab sBLA for pediatric ulcerative colitis and Crohn's disease

ByMorgan Ebert, Executive Editor
June 10th 2026
FDA approves lebrikizumab every-8-week maintenance dosing for moderate-to-severe atopic dermatitis

FDA approves lebrikizumab every-8-week maintenance dosing for moderate-to-severe atopic dermatitis

ByMorgan Ebert, Executive Editor
June 10th 2026
New sunscreen ingredient clears FDA for the first time since the 1990s

New sunscreen ingredient clears FDA for the first time since the 1990s

ByMorgan Ebert, Executive Editor
June 9th 2026
FDA grants GEn-1123 rare disease designations for Duchenne muscular dystrophy

FDA grants GEn-1123 rare disease designations for Duchenne muscular dystrophy

ByMorgan Ebert, Executive Editor
June 9th 2026

Latest CME

 Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update
Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

View more
Advertisement
Advertisement

Trending on Contemporary Pediatrics

1

FDA grants GEn-1123 rare disease designations for Duchenne muscular dystrophy

2

New sunscreen ingredient clears FDA for the first time since the 1990s

3

FDA accepts vedolizumab sBLA for pediatric ulcerative colitis and Crohn's disease

4

FDA approves lebrikizumab every-8-week maintenance dosing for moderate-to-severe atopic dermatitis

5

FDA expands marstacimab (HYMPAVZI) approval to children ages 6–11 and hemophilia patients with inhibitors

  • About Us
  • Advertise
  • Contact Us
  • Editorial
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us